+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Frailty in Parkinson's disease and its clinical implications

Frailty in Parkinson's disease and its clinical implications

Parkinsonism and Related Disorders 14(4): 334-337

The purpose of our study was to determine the prevalence of frailty in Parkinson's disease (PD) patients and the relationship between individual frailty criteria and the severity of PD. We measured the five components of frailty (Fried et al.) and the severity of PD (unified Parkinson's disease rating scale (UPDRS)) in 50 optimally treated PD patients. Frailty was more prevalent in PD patients. While UPDRS scores differed between frail and non-frail participants (44.8+/-15.8 vs. 31.4+/-12.7, P<0.002), higher scores were not indicative of frailty. Weekly caloric expenditure best predicted frailty status (OR=22.0 [4.5,107.8]). Frailty and PD bear distinct therapeutic and prognostic significance; however, their clinical picture may overlap and screening PD patients for frailty may be warranted.

(PDF emailed within 0-6 h: $19.90)

Accession: 053297306

Download citation: RISBibTeXText

PMID: 17988926

DOI: 10.1016/j.parkreldis.2007.10.004

Related references

Frailty and Parkinson's disease: theories and clinical implications. Parkinsonism and Related Disorders 14(4): 271-272, 2007

An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease. Medicina Clinica 94(15): 585-595, 1990

Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurology 70(11): 1359-1366, 2014

The Clinical Frailty Scale predicts inpatient mortality in older hospitalised patients with idiopathic Parkinson's disease. Journal of the Royal College of Physicians of Edinburgh 48(2): 103-107, 2018

Concurrence of Frailty and Parkinson's Disease. Journal of Frailty and Aging 1(3): 123-127, 2012

Identifying frailty: do the Frailty Index and Groningen Frailty Indicator cover different clinical perspectives? a cross-sectional study. Bmc Family Practice 14: 64, 2013

Clinical implications of Parkinson's disease genetics. Seminars in Neurology 26(5): 492-498, 2006

Survey on general knowledge on Parkinson's disease in patients with Parkinson's disease and current clinical practice for Parkinson's disease among general neurologists from Southwest China. Clinical Neurology and Neurosurgery 118: 16-20, 2014

The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 35(4): 522-526, 1985

α-Synuclein oligomers and clinical implications for Parkinson disease. Annals of Neurology 73(2): 155-169, 2013

Parkinson's disease following hypothyroidism: clinical and therapeutic implications. La Tunisie Medicale 91(2): 168-170, 2013

Biological and Clinical Implications of Comorbidities in Parkinson's Disease. Frontiers in Aging Neuroscience 9: 394, 2017

The clinical heterogeneity of Parkinson's disease and its therapeutic implications. European Journal of Neuroscience 2018, 2018

Parkinson's disease: acquired frailty of archaic neural networks?. Journal of the Neurological Sciences 314(1-2): 143-151, 2012

Physical Activity across Frailty Phenotypes in Females with Parkinson's Disease. Journal of Aging Research 2012: 468156, 2012